Design of drug molecule based structure for smad 3 protein and its insilico research of leukemia utilizing bioinformatics software

0Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The Research work on rational drug molecules design for Smad3,the conclusion is that out of all the inhibitors chosen for the docking, PTHrP emerged to be the best inhibitor for the protein Smad3.The precise reason for it was its docking energy which was the lowest (docked energy =-29.73), among all other inhibitors used. Hence the conclusion is that Smad3 is the best inhibitor, for Smad3. Hence the task was completed successfully. There are many reasons and factors responsible for induction of cancer. Leukemia is a type of cancer in blood or bone marrow and is characterized by an irregular proliferation of white blood cells.

Cite

CITATION STYLE

APA

Manikandan, A., Jayalakshmi, T., & Ramesh Babu, P. B. (2019). Design of drug molecule based structure for smad 3 protein and its insilico research of leukemia utilizing bioinformatics software. International Journal of Innovative Technology and Exploring Engineering, 8(9 Special Issue 2), 301–306. https://doi.org/10.35940/ijitee.I1062.0789S219

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free